IL6 and fatty liver disease: Conversely, the prevention of fatty liver, together with the down-regulation of pro-inflammatory mediators caused by PTS in the adipose tissue (Ccl2, Itgax) and liver (IL-6), might have buffered the dietary effects and protected metabolic health, as shown by the better response of PTS-fed mice in the OGTT.